US Patent 10111966 Methods for the depletion of CD117+ cells
Patent 10111966 was granted and assigned to Magenta Therapeutics on October, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10111966 Methods for the depletion of CD117+ cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
